# A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age

> **NCT00171041** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 265 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan

## Key facts

- **NCT ID:** NCT00171041
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171041, "A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00171041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*